In general, the gene expression of FABP3 correlated positively with MetS phenotypes that are known to have beneficial effects in metabolic profiles including HDL-cholesterol (βHDL-c = 0.42) and adiponectin (βadiponectin = 0.24). Here, ADIPOQ is linked to metabolic syndrome.